HuGE Literature Finder
Records
1
-
30
| Effects of methylenetetrahydrofolate reductase single-nucleotide polymorphisms on breast, cervical, ovarian, and endometrial cancer susceptibilities. Chronic diseases and translational medicine 2021 Sep 7 (3): 169-181. Wang Zheng, Li Kai, Ouyang Ling, Iko Hidasa, Safi Ahmad Javid, Gao Sh |
| A Retrospective Cross-Sectional Cohort Trial Assessing the Prevalence of MTHFR Polymorphisms and the Influence of Diet on Platinum Resistance in Ovarian Cancer Patients. Cancers 2021 10 13 (20): . Phillips-Chavez Caitlin, Coward Jermaine, Watson Michael, Schloss Jan |
| Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses. Journal of ovarian research 2021 11 14 (1): 153. Tanha Kiarash, Mottaghi Azadeh, Nojomi Marzieh, Moradi Marzieh, Rajabzadeh Rezvan, Lotfi Samaneh, Janani Lei |
| Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer. Bioscience reports 2020 Jul . Xiong Ying, Bian Ce, Lin Xiaojuan, Wang Xiaoli, Xu Kehui, Zhao X |
| Association of MTHFR 677C>T Polymorphism with Susceptibility to Ovarian and Cervical Cancers: A Systematic Review and Meta-Analysis. Asian Pacific journal of cancer prevention : APJCP 2019 09 20 (9): 2569-2577. Karimi-Zarchi Mojgan, Moghimi Mansour, Abbasi Hajar, Hadadan Amaneh, Salimi Erfaneh, Morovati-Sharifabad Majid, Akbarian-Bafghi Mohammad Javad, Zare-Shehneh Masoud, Mosavi-Jarrahi Alireza, Neamatzadeh Hosse |
| MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls. OncoTargets and therapy 2017 10 227-238. He Lilin, Shen Yongxia |
| ASSOCIATION OF MTHFR A1298C POLYMORPHISM WITH BREAST CANCER AND/OR OVARIAN CANCER RISK: AN UPDATED META-ANALYSIS. African journal of traditional, complementary, and alternative medicines : AJTCAM 2016 13 (5): 72-86. Liu Wei, Li Yi, Li Rui, Han Xiao, Ma Ying, Liu Bin, Kong Xiangzh |
| In human alleles specific variation of MTHFR C677T and A1298C associated "risk factor" for the development of ovarian cancer. Journal of experimental therapeutics & oncology 2015 11 (1): 67-70. Singh Anupama, Pandey S, Pandey L K, Saxena Ajit |
| MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis. Genetics and molecular research : GMR 2015 14 (3): 8211-8. Shi X Y, Shen |
| Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival. Gynecologic oncology 2014 Mar 132 (3): 566-72. Dixon S C, Ibiebele T I, Protani M M, Beesley J, deFazio A, Crandon A J, Gard G B, Rome R M, Webb P M, Nagle C M, |
| Association between MTHFR gene polymorphism and the risk of ovarian cancer: a meta-analysis of the literature. Current pharmaceutical design 2014 20 (11): 1632-8. Pu Danhua, Jiang Shi-Wen, Wu J |
| Folate intake and MTHFR polymorphism C677T is not associated with ovarian cancer risk: evidence from the meta-analysis. Molecular biology reports 2013 Dec 40 (12): 6547-60. Li Chenglin, Chen Peizhan, Hu Pingting, Li Mian, Li Xiaoguang, Guo He, Li Jingquan, Chu Ruiai, Zhang Wei, Wang H |
| The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals. Molecular biology reports 2013 Mar 40 (3): 2061-8. Ma Chengbin, Liu Yan, Zhang Wenying, Liu Pi |
| MTHFR polymorphisms and ovarian cancer risk: a meta-analysis. Molecular biology reports 2012 Nov 39 (11): 9863-8. Liu Lu, Liao Shao-Guang, Wang Ya-J |
| Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British journal of cancer 2012 Jun 106 (12): 2016-24. Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott R J, McGuffog L, Healy S, Sinilnikova O M, Rennert G, Lejbkowicz F, Flugelman A, Andrulis I L, Glendon G, Ozcelik H, , Thomassen M, Paligo M, Aretini P, , Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, Karlsson P, Stenmark-Askmalm M, Melin B, Nathanson K L, Domchek S M, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Serrano P, Osorio A, Cajal T R, Tsitlaidou M, Benítez J, Gilbert M, , Rookus M, Aalfs C M, Kluijt I, Boessenkool-Pape J L, Meijers-Heijboer H E J, Oosterwijk J C, van Asperen C J, Blok M J, Nelen M R, van den Ouweland A M W, Seynaeve C, van der Luijt R B, Devilee P, , Easton D F, Peock S, Frost D, Platte R, Ellis S D, Fineberg E, Evans D G, Lalloo F, Eeles R, Jacobs C, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Godwin A, Bove B, , Stoppa-Lyonnet D, Caux-Moncoutier V, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Boutry-Kryza N, Pujol P, Coupier I, Peyrat J-P, Vennin P, Muller D, Fricker J-P, Venat-Bouvet L, Johannsson O Th, Isaacs C, Schmutzler R, Wappenschmidt B, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Preisler-Adams S, Simard J, Soucy P, Durocher F, Chenevix-Trench G, Beesley J, Chen X, , Rebbeck T, Couch F, Wang X, Lindor N, Fredericksen Z, Pankratz V S, Peterlongo P, Bonanni B, Fortuzzi S, Peissel B, Szabo C, Mai P L, Loud J T, Lubinski J, |
| Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish population. Molecular biology reports 2012 May 39 (5): 5553-60. Pawlik Piotr, Mostowska Adrianna, Lianeri Margarita, Sajdak Stefan, K?dzia Helena, Jagodzinski Pawe? |
| Folate intake and methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers for ovarian cancer risk. International journal of molecular sciences 2012 13 (4): 4009-20. Zhang Li, Liu Wenxin, Hao Quan, Bao Lewen, Wang |
| Lack of significance of the BRCA2 promoter methylation status in different genotypes of the MTHFR a1298c polymorphism in ovarian cancer cases in Iran. Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 1833-6. Darehdori Ahmad Shabanizadeh, Dastjerdi Mehdi Nikbakht, Dahim Hajar, Slahshoor Mohammadreza, Babazadeh Zahra, Taghavi Mohammad Mohsen, Taghipour Zahra, Gaafarineveh Hamidre |
| Methylenetetrahydrofolate reductase gene polymorphisms as predictive and prognostic biomarkers in ovarian cancer risk. Asian Pacific journal of cancer prevention : APJCP 2012 13 (2): 569-73. Gao Song, Liu Ning, Ma Yang, Ying L |
| MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2012 13 (8): 3937-42. Ding Xiao-Ping, Feng Li, Ma |
| Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer. European journal of clinical nutrition 2011 Oct 65 (10): 1133-40. Webb P M, Ibiebele T I, Hughes M C, Beesley J, van der Pols J C, Chen X, Nagle C M, Bain C J, Chenevix-Trench G, , |
| Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie 2011 34 (8-9): 422-6. Prasad Vidudala V T S, Wilkhoo Harpre |
| Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clinical cancer research : an official journal of the American Association for Cancer Research 2011 2 17 (8): 2170-80. Woloszynska-Read Anna, Zhang Wa, Yu Jihnhee, Link Petra A, Mhawech-Fauceglia Paulette, Collamat Golda, Akers Stacey N, Ostler Kelly R, Godley Lucy A, Odunsi Kunle, Karpf Adam |
| MTHFR polymorphisms in relation to ovarian cancer risk. Gynecologic oncology 2010 Nov 119 (2): 319-24. Terry Kathryn L, Tworoger Shelley S, Goode Ellen L, Gates Margaret A, Titus-Ernstoff Linda, Kelemen Linda E, Sellers Thomas A, Hankinson Susan E, Cramer Daniel |
| [No association between MTHFR 677C>T polymorphism and ovarian cancer risk in BRCA1 mutation carriers in Wielkopolska region]. Ginekologia polska 2010 Jul 81 (7): 506-10. Magnowski Piotr, Seremak-Mrozikiewicz Agnieszka, Nowak-Markwitz Ewa, Kurzawi?ska Grazyna, Drews Krzysztof, Spaczy?ski Mar |
| Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast cancer research and treatment 2007 Sep 104 (3): 299-308. Jakubowska Anna, Gronwald Jacek, Menkiszak Janusz, Górski Bohdan, Huzarski Tomasz, Byrski Tomasz, Edler Lutz, Lubi?ski Jan, Scott Rodney J, Hamann U |
| Methyl group metabolism gene polymorphisms as modifier of breast cancer risk in Italian BRCA1/2 carriers. Breast cancer research and treatment 2007 May 103 (1): 29-36. Pepe C, Guidugli L, Sensi E, Aretini P, D'Andrea E, Montagna M, Manoukian S, Ottini L, Radice P, Viel A, Bevilacqua G, Caligo M |
| Effect of methylenetetrahydrofolate reductase 677C-->T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. International journal of cancer. Journal international du cancer 2003 Jan 103 (3): 294-9. Toffoli Giuseppe, Russo Antonio, Innocenti Federico, Corona Giuseppe, Tumolo Salvatore, Sartor Franca, Mini Enrico, Boiocchi Mau |
| Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. European journal of cancer (Oxford, England : 1990) 2000 Dec 36 (18): 2313-6. Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman |
| Homocysteinemia is inversely correlated with platelet count and directly correlated with sE- and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase. Platelets 0 16 (3-4): 185-90. Rongioletti Mauro, Baldassini Mauro, Papa Fabrizio, Capoluongo Ettore, Rocca Bianca, Cristofaro Raimondo De, Salvati Giuseppina, Larciprete Giovanni, Stroppolo Annalisa, Angelucci Piero Antonio, Cirese Elio, Ameglio Fran |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: